Category Archives: News


Have you heard of EuroScience Open Forum (ESOF)? ESOF is the largest European science conference gathering world famous researchers and scientists from all disciplines. It takes place every two years. The sessions include a science, a science to business and a career programme (to be announced soon).

The next ESOF conference will take place on 23-27 July 2016 and will be followed by a satellite conference for MSCA fellows and alumni on 28- 29 July 2016 in Manchester city.

Registrations to MSCA conference are free and will open in January 2016, and MSCA fellows will have the opportunity to register to the main ESOF conference at a special discount price.

So before planning your Summer holidays, bear in mind the MSCA and ESOF conferences!

For a preview of our programme for the satellite conference >>>

We look forward to seeing you in Manchester!

Friday, 9 october, 2015 – 11:00, room 2025, building U3.
Dipartimento di Biotecnologie e Bioscienze
University of Milano-Bicocca

MSCA-ITN-2014 ETN Project “Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.”

Professor David Andreu – Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Barcelona, Spain

download the flyer


TOLLerant European Summer School 2015

Toolerant & SUMMER SCHOOL per newsletter
Scientific Responsible: Prof. Francesco Peri

– Lectures
22–23 September 2015
Read more

– Dissemination Event
“The wonderful journey of a molecule in our body: from drugs to functional food”
24 September 2015

Read more

– Registration
Sign up


MSCA-ITN-2014 ETN Project “Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.”

21 July 2015
University of Milano-Bicocca – How to reach us
Piazza della Scienza, 2
Building: U3 Room: 2025

10.00 – “NIR and lanthanide based chromophores for two-photon bio-imaging applications”
Olivier Maury, Director of CNRS research “Chimie pour l’optique”, Laboratory of Chemistry – École normale supérieure Lyon (France)

11.00 – “High-resolution optical imaging of living cells by coherent Raman scattering microscopy”
Professor Thomas R. Huser, Biomolecular Photonics, Department of Physics – University of Bielefeld (Germany)

The Flyer

workshop3 workshop1a


The Computational Chemical Biological group of CIB-CSIC organized an outreach activity at Aquinas American School. Students of different ages participated in an interactive workshop on 3D visualization of different molecules, complexes and simulations: starting from simple structures such as glucose and water, to DNA and proteins (in complex with drugs), and finally ribosome.
The Computational Chemical Biology group is partner of EU-funded Marie Curie FP7-ITN-GLYCOPHARM and H2020-ETN-TOLLerant projects.

Positions Available

H2020-MSCA-ITN-2014-ETN: Marie Skłodowska Curie Innovative Training Networks

PhD position in Biophysics
UNIBI – University of Bielefeld, Germany

Prof. Thomas Huser – Biomolecular photonics group.

Project TOLLerant (Toll-like receptor 4 activation and function in diseases: an integrated chemical-biology approach)
Grant Agreement n. 642157

The deadline for applications is July 31, 2015.

More Info: Vacancy ESR_UNIBI

Riga, Latvia, 28-29 May 2015

Higher education and international affairs; Erasmus+
Research careers; Marie Skłodowska-Curie actions

Programme Riga

MSCA-ITN-2014-ETN: Marie Skłodowska- Curie Innovative Training Networks (ITN-ETN)
TOLLerant “Toll-Like Receptot 4 activation and function in diseases: an integrated chemical-biology approach”
Grant agreement nº: 642157
ESR Position in Nanoimmunology: Nanofunctionalisation of TLR4 agonists and antagonists –Platforms for enhanced delivery with multimodal imaging tracking

Applications are invited for a 36 months position as early-stage researcher (ESR) to work on the Marie Skłodowska-Curie Innovative Training Network TOLLerant from May/June 2015.

The research, which will be carried out at CIC biomaGUNE (San Sebastián, Spain), aims to develop biocompatible (PLGA, gold and iron oxide nanoparticles) with synthetically defined sizes and shapes and a payload of new TLR4 agonists and antagonists, designing and conducting experiments to optimize and scale-up synthesis procedures. These nanoparticles will be simultaneously functionalised using selfassembly methods with an organic dye and gamma or positron emitting radionuclides. Some nanoparticles will be further functionalized with additional ligands actively targeting dendritic cell or macrophage-specific receptors. The goal is to modulate and optimize the in vivo activity of the TLR4 ligands, limiting toxicity. Multimodal imaging and tracking will be applied to assess pharmacokinetic properties and biological fate of the nanosystems, and to gain a fundamental understanding of biological and biochemical processes occurring in vitro and in vivo. Relevant publication: Small, 2014, 10, 5054–5067. doi: 10.1002/smll.201401353.
The successful candidate will join the laboratory of Professor Juan C. Mareque-Rivas and participate in the network’s training activities and work placements at the laboratories of the participating academic and industrial teams. Regular meetings and workshops within the EU-funded TOLLerant International Training Network will supplement the training and support provided at CIC biomaGUNE and the University of the Basque Country.
TOLLerant is a EU funded programme which brings together 8 academic and 2 industrial full partners and 3 associated partners. TOLLerant aims to develop a new generation of innovative, TLR4-based therapeutics, to be used as vaccine adjuvants, anti-sepsis agents, and anti-inflammatory agents to treat chronic inflammations (allergy, asthma). The training programme is designed to provide Early Stage Researchers (ESR) with broad competences, experience and skills in the cutting-edge, inter-disciplinary research field of chemical biology related to the molecular mechanisms of innate immunity and inflammation.

Applicants should meet the following eligibility criteria:
– Have a Diploma and/or a Master Degree in chemistry, biology, chemical engineering, biochemical engineering, biotechnology or biomedical engineering.
– Have less than 4 years research experience at the signature of the contract (measured from the time the Master’s degree has been obtained).
– At the time of application you should not have a PhD degree (although applications will be accepted also from candidates enrolled in a PhD and due to defend the thesis in the next few months)
– Not have resided or carried out main activity in Spain for more than 12 months in the last 3 years immediately prior to the reference recruitment date.
– Excellent knowledge of the English language (spoken and written / proficiency level)

The ESR will be contractually employed by CIC biomaGUNE and will be covered under the social security scheme. He or she will receive a Monthly Living Allowance plus a Mobility Allowance compliant with the applicable EC Marie Skłodowska-Curie Actions-ITN general conditions.

Application procedure:
Candidates should submit a CV, cover letter and the names and contact details of at least 3 references by e-mail to indicating reference nº 312_TOLLerant in the subject. The deadline for application is 01/05/2015

Career Stage
Early stage researcher or 0-4 yrs (Post graduate)

Research Profiles
First Stage Researcher (R1)

Is the job funded through the EU Research Framework Programme?
H2020/Marie Curie Actions

Project’s Marie Curie Grant Agreement Number

Job details_TOLLerant (JCMR) CIC_biomaGUNE